Αποτελέσματα Αναζήτησης
Since 1997 alone, companies funded by Cardinal have a cumulative market valuation exceeding $15 Billion. Cardinal’s investors include university endowments, foundations, pension funds, banks, and insurance companies.
- Team
The operating and investment backgrounds of the Cardinal’s...
- Companies
Cardinal Partners is lead investor, raising capital and IPO...
- Our Vision
Venture Partner, Cardinal Partners. Investment Strategy....
- Contact
Princeton Office (HQ) 230 Nassau Street, Princeton, NJ 08542...
- Venture Partners
Venture Partners; Venture Partners Together we can achieve...
- John Clarke
John entered the venture industry in 1982 with DSV Partners,...
- Thomas Mckinley
Thomas McKinley has over 35 years of venture capital...
- Events
© 2019 Cardinal Partners. All rights reserved. Scroll to top
- Team
Founded in 1996, Cardinal Partners is a venture capital firm based in Princeton, New Jersey. The firm prefers to invest in the healthcare, consumer, machine learning, blockchain, technology, and life sciences sectors.
Cardinal Partners is a venture capital partnership focused exclusively on healthcare investing.
Are you about starting a venture capital firm? If YES, here’s a complete sample venture capital business plan template & feasibility report you can use for FREE to raise money.
Cardinal Partners is a venture capital firm focused exclusively on healthcare investing. The firm specializes in early stage financing rounds, usually as the lead investor in the initial financing round of a growth company. Headquarters Location. 230 Nassau Street. Princeton, New Jersey, 08542, United States. 609.924.6452. Suggest an edit.
Venture Partner, Cardinal Partners. Investment Strategy. Understanding the complexities of the health care system is the most important step towards investment success in the sector. STAGE. Institutional financings, selective early stage rounds, opportunistic recapitalization and/or ‘re-start’ rounds. SECTOR FOCUS.
Cardinal Partners operates as a venture capital firm. The Company invests in biotechnology, medical devices, and information technology and services sectors.